|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
203 a.a.
|
 |
|
|
|
|
|
|
|
109 a.a.
|
 |
|
|
|
|
|
|
|
232 a.a.
|
 |
|
|
|
|
|
|
|
202 a.a.
|
 |
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Growth factor
|
 |
|
Title:
|
 |
Crystal structure of 7s ngf: a complex of nerve growth factor with four binding proteins (serine proteinases)
|
|
Structure:
|
 |
Nerve growth factor. Chain: a, x. Synonym: 7s ngf. Nerve growth factor. Chain: b, y. Synonym: 7s ngf. Nerve growth factor. Chain: g, z. Synonym: 7s ngf.
|
|
Source:
|
 |
Mus musculus. House mouse. Organism_taxid: 10090. Strain: swiss webster. Organ: male submandibular gland. Organ: male submandibular gland
|
|
Biol. unit:
|
 |
Hexamer (from
)
|
|
Resolution:
|
 |
|
3.15Å
|
R-factor:
|
0.246
|
R-free:
|
0.282
|
|
|
Authors:
|
 |
B.D.V.Bax,T.L.Blundell,J.Murray-Rust,N.Q.Mcdonald
|
Key ref:
|
 |
B.Bax
et al.
(1997).
Structure of mouse 7S NGF: a complex of nerve growth factor with four binding proteins.
Structure,
5,
1275-1285.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
08-Aug-97
|
Release date:
|
27-May-98
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P00757
(K1KB4_MOUSE) -
Kallikrein 1-related peptidase-like b4 from Mus musculus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
256 a.a.
203 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P01139
(NGF_MOUSE) -
Beta-nerve growth factor from Mus musculus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
241 a.a.
109 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B, G, X, Y, Z:
E.C.3.4.21.35
- tissue kallikrein.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Preferential cleavage of Arg-|-Xaa bonds in small molecule substrates. Highly selective action to release kallidin (lysyl-bradykinin) from kininogen involves hydrolysis of Met-|-Xaa or Leu-|-Xaa. The rat enzyme is unusual in liberating bradykinin directly from autologous kininogens by cleavage at two Arg-|-Xaa bonds.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Structure
5:1275-1285
(1997)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of mouse 7S NGF: a complex of nerve growth factor with four binding proteins.
|
|
B.Bax,
T.L.Blundell,
J.Murray-Rust,
N.Q.McDonald.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
BACKGROUND: Nerve growth factor (NGF) is a neurotrophic factor that promotes the
differentiation and survival of certain populations of neurons in the central
and peripheral nervous systems. 7S NGF is an alpha 2 beta 2 gamma 2 complex in
which the beta-NGF dimer (the active neurotrophin) is associated with two
alpha-NGF and two gamma-NGF subunits, which belong to the glandular kallikrein
family of serine proteinases. The gamma-NGF subunit is an active serine
proteinase capable of processing the precursor form of beta-NGF, whereas
alpha-NGF is an inactive serine proteinase. The structure of 7S NGF could be
used as a starting point to design inhibitors that prevent NGF binding to its
receptors, as a potential treatment of neurodegenerative diseases. RESULTS: The
crystal structure of 7S NGF shows that the two gamma-NGF subunits make extensive
interactions with each other around the twofold axis of the complex and have the
C-terminal residues of the beta-NGF subunits bound within their active sites.
The 'activation domain' of each of the alpha-NGF subunits is in an inactive
(zymogen-like) conformation and makes extensive interactions with the beta-NGF
dimer. The two zinc ions that stabilize the complex are located at the
relatively small interfaces between the alpha-NGF and gamma-NGF subunits.
CONCLUSIONS: The structure of 7S NGF shows how the twofold axis of the central
beta-NGF dimer organizes the symmetry of this multisubunit growth factor
complex. The extensive surface of beta-NGF buried within the 7S complex explains
the lack of neurotrophic activity observed for 7S NGF. The regions of the
beta-NGF dimer that contact the alpha-NGF subunits overlap with those known to
engage NGF receptors. Two disulphide-linked loops on alpha-NGF make multiple
interactions with beta-NGF and suggest that it might be possible to design
peptides that inhibit the binding of beta-NGF to its receptors.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
Figure 7.
Figure 7. Electron density surrounding the zinc ion
(off-white sphere) bound between the a1 and g1 subunits. The
final 2F[o] -F[c] map is shown contoured at 1.5s (cyan) and 6s
(off-white).
|
 |
|
|
|
| |
The above figure is
reprinted
by permission from Cell Press:
Structure
(1997,
5,
1275-1285)
copyright 1997.
|
|
| |
Figure was
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
P.Goettig,
V.Magdolen,
and
H.Brandstetter
(2010).
Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs).
|
| |
Biochimie,
92,
1546-1567.
|
 |
|
|
|
|
 |
A.Hoffmann,
A.Funkner,
P.Neumann,
S.Juhnke,
M.Walther,
A.Schierhorn,
U.Weininger,
J.Balbach,
G.Reuter,
and
M.T.Stubbs
(2008).
Biophysical characterization of refolded Drosophila Spätzle, a cystine knot protein, reveals distinct properties of three isoforms.
|
| |
J Biol Chem,
283,
32598-32609.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Hoffmann,
P.Neumann,
A.Schierhorn,
and
M.T.Stubbs
(2008).
Crystallization of Spätzle, a cystine-knot protein involved in embryonic development and innate immunity in Drosophila melanogaster.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun,
64,
707-710.
|
 |
|
|
|
|
 |
M.Debela,
V.Magdolen,
N.Schechter,
M.Valachova,
F.Lottspeich,
C.S.Craik,
Y.Choe,
W.Bode,
and
P.Goettig
(2006).
Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences.
|
| |
J Biol Chem,
281,
25678-25688.
|
 |
|
|
|
|
 |
G.Laxmikanthan,
S.I.Blaber,
M.J.Bernett,
I.A.Scarisbrick,
M.A.Juliano,
and
M.Blaber
(2005).
1.70 A X-ray structure of human apo kallikrein 1: structural changes upon peptide inhibitor/substrate binding.
|
| |
Proteins,
58,
802-814.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.Muangman,
L.A.Muffley,
J.P.Anthony,
M.L.Spenny,
R.A.Underwood,
J.E.Olerud,
and
N.S.Gibran
(2004).
Nerve growth factor accelerates wound healing in diabetic mice.
|
| |
Wound Repair Regen,
12,
44-52.
|
 |
|
|
|
|
 |
G.Settanni,
A.Cattaneo,
and
P.Carloni
(2003).
Molecular dynamics simulations of the NGF-TrkA domain 5 complex and comparison with biological data.
|
| |
Biophys J,
84,
2282-2292.
|
 |
|
|
|
|
 |
F.X.Gomis-Rüth,
A.Bayés,
G.Sotiropoulou,
G.Pampalakis,
T.Tsetsenis,
V.Villegas,
F.X.Avilés,
and
M.Coll
(2002).
The structure of human prokallikrein 6 reveals a novel activation mechanism for the kallikrein family.
|
| |
J Biol Chem,
277,
27273-27281.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.C.Hsieh,
and
B.S.Cooperman
(2002).
Inhibition of prostate-specific antigen (PSA) by alpha(1)-antichymotrypsin: salt-dependent activation mediated by a conformational change.
|
| |
Biochemistry,
41,
2990-2997.
|
 |
|
|
|
|
 |
T.Oka,
T.Hakoshima,
M.Itakura,
S.Yamamori,
M.Takahashi,
Y.Hashimoto,
S.Shiosaka,
and
K.Kato
(2002).
Role of loop structures of neuropsin in the activity of serine protease and regulated secretion.
|
| |
J Biol Chem,
277,
14724-14730.
|
 |
|
|
|
|
 |
Z.Zhu,
J.Kleeff,
H.Kayed,
L.Wang,
M.Korc,
M.W.Büchler,
and
H.Friess
(2002).
Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells.
|
| |
Mol Carcinog,
35,
138-147.
|
 |
|
|
|
|
 |
E.M.Shooter
(2001).
Early days of the nerve growth factor proteins.
|
| |
Annu Rev Neurosci,
24,
601-629.
|
 |
|
|
|
|
 |
H.Czapinska,
and
J.Otlewski
(1999).
Structural and energetic determinants of the S1-site specificity in serine proteases.
|
| |
Eur J Biochem,
260,
571-595.
|
 |
|
|
|
|
 |
I.L.Shamovsky,
G.M.Ross,
R.J.Riopelle,
and
D.F.Weaver
(1999).
The interaction of neurotrophins with the p75NTR common neurotrophin receptor: a comprehensive molecular modeling study.
|
| |
Protein Sci,
8,
2223-2233.
|
 |
|
|
|
|
 |
T.Kishi,
M.Kato,
T.Shimizu,
K.Kato,
K.Matsumoto,
S.Yoshida,
S.Shiosaka,
and
T.Hakoshima
(1999).
Crystal structure of neuropsin, a hippocampal protease involved in kindling epileptogenesis.
|
| |
J Biol Chem,
274,
4220-4224.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
N.Beglova,
L.LeSauteur,
I.Ekiel,
H.U.Saragovi,
and
K.Gehring
(1998).
Solution structure and internal motion of a bioactive peptide derived from nerve growth factor.
|
| |
J Biol Chem,
273,
23652-23658.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
| |